NCT05453786

A Pharmacokinetic Study of SID1903 (FDC of Dapagliflozin and Sitagliptin) in Healthy Adult Volunteers

A Phase 1 Clinical Trial to Compare and Evaluate Safety and Pharmacokinetic Characteristics After Administration of SID1903 (Fixed-dose Combination) or Loose Combination in Healthy Adult Volunteers

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 51 (actual)
• Sponsor: SK Chemicals Co., Ltd. · Industry
• Sex: All
• Age: 19 Years – 55 Years
• Healthy volunteers: Accepted

Summary

This study is to compare and evaluate the safety and pharmacokinetic characteristics (PK) after administration of SID1903 and SID1903-R1/SID1903-R2 in healthy adult volunteers.

Conditions

• Healthy Subjects

Interventions

Type	Name	Description
DRUG	SID1903	Single oral administration of SID1903 after an overnight fast
DRUG	SID1903-R1/SID1903-R2	Single oral administration of SID1903-R1 and SID1903-R2 after an overnight fast

Timeline

• Start date: 2022-06-23
• Primary completion: 2022-08-01
• Completion: 2022-08-11
• First posted: 2022-07-12
• Last updated: 2022-10-26

Locations

1 site across 1 country: South Korea